The global prostate health market, encompassing therapies, diagnostics, and preventive solutions for conditions such as benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer, is projected to grow at a CAGR of 9.1% during the forecast period, reaching USD 68.0 billion by 2030. Rising awareness of men’s health, increasing screening rates, and...